Royal Philips has revealed the augmented reality concept for image-guided minimally invasive therapies it developed with Microsoft.

The FDA has published a statement emphasizing that thermography is not cleared as an alternative to mammography for breast cancer screening or diagnosis. This comes on the heels of the agency sending La Mesa, California-based Total Thermal Imaging a warning letter for marketing "an unapproved thermography device as a sole screening device for breast cancer and other diseases.”

General Electric (GE) announced on Monday, Feb. 25, that it has entered into a definitive agreement to sell its biopharma business to Danaher Corporation for $21.4 billion. This could significantly impact the company’s plans for an initial public offering (IPO) for GE Healthcare.

Numerous studies have shown that clinical decision support (CDS) can help reduce unnecessary imaging. According to a new study in the American Journal of Roentgenology, however, not enough research has focused on how CDS tools impact less experienced providers such as house staff physicians.

Imagers challenged to complete arm MR scans for extremely claustrophobic or morbidly obese patients can do the job with a standard scanner, a wrist and elbow coil—and enough space behind the scanner for the patient to sit or stand alongside.

Travel and wait times associated with receiving healthcare services are higher than in any other service category, according to a new report from Altarum.

Joseph J. Cappello, executive director of Are You Dense and Are You Dense Advocacy, spoke to Radiology Business about how it felt to finally see federal breast density notification requirements signed into law.

RBJ asked for—and received—in-depth answers to six high-level questions about data analytics. What all these Q&A sets have in common is the supplying of a fresh insight or two (or three) into tapping data for its power to prove value and bolster the bottom line.